Strong ULT Freezer Orders for First Month of 2021 for Reflect Scientific Inc.
OREM, Utah, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Year: 2021
Galecto to Present at Upcoming Investor Conferences
BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments...
AREV Appoints Dr. Roscoe Moore to Join the Advisory Board
VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is...
NGM Bio Announces Upcoming Oral Presentation of Phase 1 Study of NGM621 in Patients with Geographic Atrophy at Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition
--Humanized IgG1 monoclonal antibody engineered to potently inhibit complement C3, with the potential for extended every eight-week dosing-- --CATALINA Phase...
Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States
Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the...
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
WARREN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...
Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor Targeting Solid Tumors
- Apollomics licenses worldwide rights (ex-China, Hong Kong and Taiwan) to develop and commercialize EO1001 - - EO1001 is an...
BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that data on...
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to...
Monopar Announces Issuance of Patent Covering Composition of Matter for MNPR-101 in Canada
WILMETTE, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing...
Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis
Triferic AVNU Triferic® AVNU (ferric pyrophosphate citrate injection), the intravenous (IV) formulation of Triferic, is now available in the United...
Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its corporate...
February is Heart Health Month: build awareness & prevent heart disease with the MUHC’s Women’s Healthy Heart Initiative (WHHI)
Women’s Healthy Heart Initiative Heart Health Month at the MUHC Foundation MONTREAL, Feb. 09, 2021 (GLOBE NEWSWIRE) -- February is...
Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate
Company Expects to Begin Phase 2 Clinical Study in the Third Quarter of 2021BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) --...
Skylight Health Names Paul Kulas Senior Vice President of Operations
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG ; OTCQX:SHGFF) (“Skylight Health” or the “Company”), announced...
Microbix Announces Material First Sales of Viral Transport Medium
Initial Production of 50,000 Vials Entirely SoldMISSISSAUGA, Ontario, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB:...
Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Cystic Fibrosis
Publication titled: “Targeting G542X CFTR Nonsense Alleles With ELX-02 Restores CFTR Function in Human-Derived Intestinal Organoids”WALTHAM, Mass., Feb. 09, 2021...
Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020
- Company had $81 million of cash and cash equivalents as of December 31, 2020, and expects to receive additional...
Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
All eight patients treated with OTL-203 show stable cognitive function, motor function and growth within the normal range at multiple...